Search Results - "Newall, A.T."

Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic by Newall, A.T., Leong, R.N.F., Nazareno, A., Muscatello, D.J., Wood, J.G., Kim, W.J.

“…•Case fatality rates (CFRs) were substantially higher in males than in females.•CFRs increased substantially from age 60 years in males and from age 70 in…”
Get full text

Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia by Reyes, J.F, Wood, J.G, Beutels, P, Macartney, K, McIntyre, P, Menzies, R, Mealing, N, Newall, A.T

“…Highlights • The Australian infant rotavirus immunisation program was estimated to be cost-saving. • Larger than predicted reductions in gastroenteritis coded…”
Get full text

Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical by Newall, A.T, Reyes, J.F, McIntyre, P, Menzies, R, Beutels, P, Wood, J.G

“…Highlights • There were substantial health benefits from the childhood PCV7 program in Australia. • Attribution of declines in non-invasive pneumonia mortality…”
Get full text

Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses by Newall, A.T, Reyes, J.F, Wood, J.G, McIntyre, P, Menzies, R, Beutels, P

“…Highlights • Economic evaluation of existing vaccine programmes presents specific challenges. • Post-implementation surveillance data have the capacity to…”
Get full text

Not as easy as it sounds: Challenges in assessing the value for money of implemented vaccination programs by Newall, A.T, Reyes, J, Wood, J.G, McIntyre, P.B, Menzies, R, Beutels, P

Get full text

Changes in seroprevalence to hepatitis A in Victoria, Australia: A comparison of three time points by Heywood, A.E, Newall, A.T, Gao, Z, Wood, J.G, Breschkin, A, Nicholson, S, Gidding, H.F, Dwyer, D.E, Gilbert, G.L, MacIntyre, C.R

“…Highlights ► We examined trends in population hepatitis A seroepidemiology over a 20-year period. ► A significant trend of increasing population hepatitis A…”
Get full text

PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination: Findings from a Literature Review by Newall, A.T, Jit, M, Beutels, P

Get full text

PIN56 EXCESS HEALTHCARE RESOURCE UTILISATION ASSOCIATED WITH PERTUSSIS INFECTION IN OLDER ADULTS by Leong, R.N., Wood, J.G., Liu, B., McIntyre, P.B., Newall, A.T.

Get full text

Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination by Chen, C., Beutels, P., Newall, A.T.

“…In many settings, serotype changes as a result of infant 13-valent pneumococcal conjugate vaccine (PCV13) programs are likely to continue after the…”
Get full text

Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States by Newall, A.T., Chen, C., Wood, J.G., Stockwell, M.S.

“…There is growing evidence that there is within (intra-) season waning of influenza vaccine protection in older adults, suggesting there may be a benefit to…”
Get full text

How can early stage economic evaluation help guide research for future vaccines? by Newall, A.T., Beutels, P., Tuffaha, H.W., Hall, P.S., Jit, M.

“…Alongside assessing value for money, early stage economic evaluation can help to provide advanced knowledge (e.g. before phase III trials) of which evidence…”
Get full text

Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia by Newall, A.T., Wood, J.G., Chen, C., McIntyre, P., Beutels, P.

Get full text

Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia by Chen, C., Beutels, P., Wood, J., Menzies, R., MacIntyre, C.R., McIntyre, P., Newall, A.T.

“…The Australian infant pneumococcal vaccination program was funded in 2005 using the 7-valent pneumococcal conjugate vaccine (PCV7) and the 13-valent conjugate…”
Get full text

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians by Dirmesropian, S., Wood, J.G., MacIntyre, C.R., Beutels, P., McIntyre, P., Menzies, R., Reyes, J.F., Chen, C., Newall, A.T.

“…The 23-valent pneumococcal polysaccharide vaccine (PPV23) has been funded under the Australia National Immunisation Program (NIP) since January 2005 for those…”
Get full text

The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia by Chen, C., Wood, J.G., Beutels, P., Menzies, R., MacIntyre, C.R., Dirmesropian, S., Reyes, J.F., McIntyre, P., Newall, A.T.

“…While the impact of the timeliness of vaccine administration has been well-studied for childhood vaccinations, there has been little detailed quantitative…”
Get full text

Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program by Dyda, A., McIntyre, P., Karki, S., MacIntyre, C.R., Newall, A.T., Banks, E., Kaldor, J., Liu, B.

“…While recommendations to vaccinate adults against pertussis exist, information on uptake for adult tetanus-diphtheria-pertussis vaccine (Tdap) among older…”
Get full text

Burden of severe rotavirus disease in Australia by Newall, Anthony T, MacIntyre, Raina, Wang, Han, Hull, Brynley, Macartney, Kristine

“…Aim:  To analyse the epidemiology of coded rotavirus hospitalisations in Australia from 1993 to 2002, with a view to understanding the pre‐vaccination burden…”
Get full text